Metabolic
MOTS-c 10mg
10mg vial
Current batch · Released 2026.04.12
Purity≥98% by HPLC
FormulaC101H152N28O22S2
Mechanism
MOTS-c is a mitochondrial-derived peptide studied for metabolic homeostasis, insulin sensitivity, and exercise capacity. Third-party COA available with batch 2.
Research applications
Mitochondrial-derived peptide for metabolic research.
References
- 1.Independent analytical results are summarized on the downloadable Certificate of Analysis.
- 2.Refer to primary literature for mechanism of action and pharmacokinetic data.
- 3.ClinicalTrials.gov — search compound name for registered studies.
- 4.PubMed — peer-reviewed publications indexed under compound name and CAS number.
Related compounds
Tirzepatide 10mg
10mg vial
In stock
Dual GLP-1 / GIP agonist for metabolic research.
$80CADView compound →
GHK-Cu 70mg
70mg vial
In stockVerified
Copper tripeptide for skin, hair, and tissue research.
$60CADView compound →
Research use only. This product is intended for laboratory research purposes only. Not for human consumption. Not a drug, food supplement, or cosmetic. Not evaluated by Health Canada or the FDA for therapeutic use.
$60CAD